Bartlett & CO. Wealth Management LLC Decreases Position in Zoetis Inc. (NYSE:ZTS)

Bartlett & CO. Wealth Management LLC lowered its position in Zoetis Inc. (NYSE:ZTS) by 6.9% during the 4th quarter, HoldingsChannel reports. The fund owned 306,590 shares of the company’s stock after selling 22,776 shares during the period. Bartlett & CO. Wealth Management LLC’s holdings in Zoetis were worth $49,953,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Advisory Alpha LLC lifted its holdings in Zoetis by 7.8% during the 4th quarter. Advisory Alpha LLC now owns 3,481 shares of the company’s stock valued at $567,000 after buying an additional 253 shares in the last quarter. Dakota Wealth Management raised its holdings in Zoetis by 3.3% in the fourth quarter. Dakota Wealth Management now owns 86,982 shares of the company’s stock worth $14,172,000 after purchasing an additional 2,805 shares in the last quarter. Simon Quick Advisors LLC boosted its holdings in shares of Zoetis by 13.8% in the 4th quarter. Simon Quick Advisors LLC now owns 3,017 shares of the company’s stock valued at $492,000 after buying an additional 366 shares in the last quarter. Commons Capital LLC grew its position in shares of Zoetis by 3.0% in the 4th quarter. Commons Capital LLC now owns 6,892 shares of the company’s stock worth $1,123,000 after buying an additional 199 shares during the last quarter. Finally, Howard Capital Management Group LLC raised its stake in shares of Zoetis by 1.6% during the 4th quarter. Howard Capital Management Group LLC now owns 106,506 shares of the company’s stock worth $17,353,000 after acquiring an additional 1,640 shares in the last quarter. 92.80% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on the company. Leerink Partners initiated coverage on Zoetis in a research report on Monday, December 2nd. They issued an “outperform” rating and a $215.00 price objective for the company. JPMorgan Chase & Co. upped their price objective on shares of Zoetis from $225.00 to $230.00 and gave the company an “overweight” rating in a report on Friday, October 11th. UBS Group began coverage on shares of Zoetis in a research report on Monday, December 9th. They set a “neutral” rating and a $196.00 target price on the stock. Leerink Partnrs upgraded shares of Zoetis to a “strong-buy” rating in a research note on Monday, December 2nd. Finally, Stifel Nicolaus cut their target price on Zoetis from $210.00 to $180.00 and set a “buy” rating on the stock in a research report on Tuesday, January 7th. One research analyst has rated the stock with a hold rating, nine have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Buy” and an average price target of $211.89.

Zoetis Stock Performance

NYSE ZTS opened at $166.64 on Thursday. The firm has a market capitalization of $75.18 billion, a P/E ratio of 31.32, a PEG ratio of 2.58 and a beta of 0.89. The stock has a 50-day simple moving average of $170.60 and a two-hundred day simple moving average of $179.89. The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.27 and a current ratio of 3.69. Zoetis Inc. has a fifty-two week low of $144.80 and a fifty-two week high of $200.53.

Zoetis (NYSE:ZTS) last announced its quarterly earnings results on Monday, November 4th. The company reported $1.58 earnings per share for the quarter, beating the consensus estimate of $1.46 by $0.12. Zoetis had a return on equity of 51.98% and a net margin of 26.55%. The company had revenue of $2.40 billion during the quarter, compared to analysts’ expectations of $2.29 billion. During the same period last year, the business earned $1.36 earnings per share. Zoetis’s quarterly revenue was up 11.6% on a year-over-year basis. On average, equities analysts forecast that Zoetis Inc. will post 5.9 earnings per share for the current year.

Zoetis Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 4th. Investors of record on Tuesday, January 21st will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 1.20%. The ex-dividend date of this dividend is Tuesday, January 21st. This is a positive change from Zoetis’s previous quarterly dividend of $0.43. Zoetis’s dividend payout ratio (DPR) is currently 37.59%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.